The Gonorrhea Epidemiology Forecast provides a comprehensive assessment of current disease burden, historical trends, and projected case growth across major global markets. Gonorrhea is a transmitted infection caused by the bacterium Neisseria gonorrhoeae. In 2023, 601,319 gonorrhea cases were reported in the United States, ranking it as the second most common nationally notifiable transmitted infection that year.

Epidemiological forecasts evaluate reported cases, incidence rates, age-specific distribution, gender trends, and antimicrobial resistance patterns. With rising STI screening programs and improved surveillance systems, reported cases have increased in several countries, reflecting both higher transmission and better detection.

How Is the Gonorrhea Epidemiology Forecast Structured Across Major Regions?

The Gonorrhea Epidemiology Forecast covers key markets including the Germany, France, Italy, Spain, United Kingdom, Japan, and India, alongside the United States.

Forecast models segment the population by age group, gender, symptomatic and asymptomatic cases, and diagnosed versus undiagnosed patients. Adolescents and young adults remain the most affected age group globally. Additionally, antimicrobial-resistant gonorrhea strains are becoming a growing concern, influencing public health strategies and future projections.

Regional variations are influenced by health awareness, access to testing, reporting systems, and public health interventions. Countries with advanced STI surveillance tend to report higher confirmed case counts due to better detection infrastructure.

Request sample report Explore

What Factors Influence the Gonorrhea Epidemiology Forecast?

Key drivers include:

Increased STI screening and awareness campaigns

Changes in behavior patterns

Urbanization and population mobility

Antimicrobial resistance trends

Public health funding and reporting systems

Improved diagnostic technologies may initially increase reported incidence, even if transmission rates stabilize.

Why Is the Gonorrhea Epidemiology Forecast Important for Stakeholders?

Healthcare policymakers, pharmaceutical companies, and diagnostic developers rely on epidemiological forecasts to guide vaccine research, antibiotic development, and prevention programs. With antimicrobial resistance posing a significant threat, accurate forecasting supports strategic planning and resource allocation.